glp 1 and botox vs GLP-1: The Injection Hypocrisy Nobody's Talking About Aesthetic restoration following GLP-1 agonist–induced

The other approved anti-fibrotic drug, nintedanib, is a non-specific tyrosine kinase inhibitor, which prevents the phosphorylation multiple targets involved in the development of fibrosis including platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), vascular endothelial growth factor receptor (VEGFR) as well as the type II TGF- receptor (105, 106)

Documents to bring: Insurance card and any pre-authorization reference numbers Most recent lab results (within 3 months: fasting glucose, HbA1c, lipid panel, liver enzymes, thyroid function) List of all current medications with dosages Written weight history with dates, methods tried, and outcomes Documentation of any weight-related diagnoses (hypertension, prediabetes, sleep apnea, PCOS, etc.) Printed list of questions (from the section above) Numbers to know: Your current BMI (calculate beforehand) Your highest adult weight and the date Your target weight or goal BMI range Duration of your most recent lifestyle intervention Relevant lab values (A1c, fasting glucose, blood pressure trend) Phrases to remember: "I would like to discuss GLP-1 receptor agonists as part of a comprehensive treatment plan" "My BMI is [number], and I have [comorbidity]

If you need to tread carefully but still want to improve constipation with a fiber supplement, acacia fiber is up your alley

Unregulated alternatives, especially those bought through social media, do not offer the same reassurance

10.1073/pnas.261708898

Results may vary, but most individuals notice improvements after 46 sessions